
TRANS GENIC GROUP INC. — Investor Relations & Filings
TRANS GENIC GROUP INC. is a biotechnology company that operates through two main business segments: Drug Discovery Support and Investment & Consulting. The Drug Discovery Support division provides comprehensive services across the entire drug development pipeline, from basic research to non-clinical and clinical trials. Core services include the contract production of genetically modified animals, particularly mice, using genome editing technologies like CRISPR/Cas9. The company also specializes in contract antibody production, glycosylation analysis, and the supply of model mice. The Investment & Consulting segment focuses on M&A, business succession, and providing advisory and support services for business revitalization.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 臨時報告書 | 2026-05-14 | Japanese | |
| 「エクソンヒト化マウス」に関する米国特許査定のお知らせ | 2026-04-22 | Japanese | |
| 確認書 | 2025-11-13 | Japanese | |
| 半期報告書-第28期(2025/04/01-2026/03/31) | 2025-11-13 | Japanese | |
| 訂正確認書 | 2025-08-01 | Japanese | |
| 訂正有価証券報告書-第27期(2024/04/01-2025/03/31) | 2025-08-01 | Japanese |
Browse filings by year
12 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
2 filings
| |||||
| 45775927 | 臨時報告書 | 2026-05-14 | Japanese | ||
| 46878231 | 「エクソンヒト化マウス」に関する米国特許査定のお知らせ | 2026-04-22 | Japanese | ||
|
2025
11 filings
| |||||
| 8275048 | 確認書 | 2025-11-13 | Japanese | ||
| 8275033 | 半期報告書-第28期(2025/04/01-2026/03/31) | 2025-11-13 | Japanese | ||
| 7859628 | 訂正確認書 | 2025-08-01 | Japanese | ||
| 7859630 | 訂正有価証券報告書-第27期(2024/04/01-2025/03/31) | 2025-08-01 | Japanese | ||
| 7241592 | 訂正臨時報告書 | 2025-07-02 | Japanese | ||
| 7242344 | 臨時報告書 | 2025-07-01 | Japanese | ||
| 7244210 | 確認書 | 2025-06-30 | Japanese | ||
| 7244204 | 内部統制報告書-第27期(2024/04/01-2025/03/31) | 2025-06-30 | Japanese | ||
| 7244201 | 有価証券報告書-第27期(2024/04/01-2025/03/31) | 2025-06-30 | Japanese | ||
| 7259223 | 臨時報告書 | 2025-06-13 | Japanese | ||
| 7266406 | 臨時報告書 | 2025-04-23 | Japanese | ||
|
2024
2 filings
| |||||
| 7298253 | 確認書 | 2024-11-13 | Japanese | ||
| 7298255 | 半期報告書-第27期(2024/04/01-2025/03/31) | 2024-11-13 | Japanese | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Alpha Tau Medical Ltd.
Clinical-stage oncology firm developing alpha radiation the…
|
DRTS | US | Professional, scientific and te… |
|
Alteogen Inc.
Biopharmaceutical firm developing biologics with proprietar…
|
196170 | KR | Professional, scientific and te… |
|
ALTERITY THERAPEUTICS LIMITED
Clinical-stage developer of disease-modifying therapies for…
|
ATH | AU | Professional, scientific and te… |
|
AlzeCure Pharma
Develops therapies for severe diseases, focusing on Alzheim…
|
ALZCUR | SE | Professional, scientific and te… |
|
AMPLIA THERAPEUTICS LIMITED
Clinical-stage developer of FAK inhibitors for solid tumors…
|
ATX | AU | Professional, scientific and te… |
|
ANAPTYSBIO, INC
Clinical-stage biotech developing immunology therapeutics f…
|
ANAB | US | Professional, scientific and te… |
|
ANATARA LIFESCIENCES LTD
Develops non-antibiotic gastrointestinal health solutions f…
|
ANR | AU | Professional, scientific and te… |
|
AngioLab, Inc.
Develops angiogenesis inhibitors for pharmaceuticals and he…
|
251280 | KR | Professional, scientific and te… |
|
Anhui Wanbang Pharmaceutical Technology Co.,Ltd.
Pharmaceutical CRO specializing in clinical trials, BE stud…
|
301520 | CN | Professional, scientific and te… |
|
Anixa Biosciences Inc
A clinical-stage biotech developing therapies and vaccines …
|
ANIX | US | Professional, scientific and te… |
TRANS GENIC GROUP INC. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/13323/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=13323 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=13323 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=13323 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 13323}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for TRANS GENIC GROUP INC. (id: 13323)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.